EGFR and breast carcinoma: They utilize PD1 and EGFR targeted nanostars for the MDA‐MB‐231 breast cancer cell line employing 170 μg mL−1 functionalized nanostars and advocate that they can control cell death specifically at the laser‐irradiated zone.